Mail-in self-collection tests for human papillomavirus (HPV) more than doubled cervical cancer screening participation among never- and under-screened U.S. women, according to a first-of-its-kind study by researchers at the University of Texas MD Anderson Cancer Center.
This article was originally published on MedicalXpress.com